TABLE 3.
Characteristics of the 6 Patients Who Progressed Directly From Stage T1 to Beyond T2 Criteria
| Patient | Age, Years |
Liver Disease Etiology |
Size at T1 Diagnosis, cm |
AFP at T1 Diagnosis, ng/mL |
Time to Progression Directly Beyond T2, Months |
Tumor Burden When Directly Beyond T2 |
AFP When Directly Beyond T2, ng/mL |
|---|---|---|---|---|---|---|---|
| 1 | 63 | HCV | 1.0 | 11.2 | 5.9 | 7 lesions up to 2.3 cm | 6.1 |
| 2 | 57 | HCV | 1.9 | 41.0 | 2.1 | 2 lesions up to 2.9 cm+portal vein tumor invasion |
32 |
| 3 | 56 | HCV | 1.4 | 13.7 | 3.6 | 3 lesions up to 4.9 cm | 15 |
| 4 | 55 | Alcohol | 1.9 | 4.0 | 4.3 | 2 lesions up to 4 cm | 4.7 |
| 5 | 58 | HBV | 1.6 | 34.3 | 12.0 | Single 11-cm lesion | 6.9 |
| 6 | 66 | NAFLD | 1.5 | 4.0 | 6.9 | Single 3-cm lesion and adrenal metastasis |
4.4 |